Benefit of Continuous Glucose Monitoring in Reducing Hypoglycemia Is Sustained Through 12 Months of Use Among Older Adults with Type 1 Diabetes

Sustainable Use of a Real-Time Continuous Glucose Monitoring System from 2018 to 2020

(2021) Joost van der Linden et al.   Diabetes Technology & Therapeutics

Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump Therapy in Older Adults With Type 1 Diabetes (ORACL): A Randomized, Crossover Trial

(2021) Sybil A. McAuley et al.   DIABETES CARE

Closed-Loop Insulin Therapy in Older Adults with Type 1 Diabetes: Real-World Data

(2021) Elena Toschi et al.   Diabetes Technology & Therapeutics

How Significant Is Severe Hypoglycemia in Older Adults With Diabetes?

(2020) Lisa Chow et al.   DIABETES CARE

Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes

(2020) Richard E. Pratley et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Sustained Impact of Real-Time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study

(2020) Sara Charleer et al.   DIABETES CARE

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

Development of a New Measure for Assessing Insulin Delivery Device Satisfaction in Patients with Type 1 and Type 2 Diabetes

(2015) William H. Polonsky et al.   Diabetes Technology & Therapeutics

National Trends in US Hospital Admissions for Hyperglycemia and Hypoglycemia Among Medicare Beneficiaries, 1999 to 2011

(2014) Kasia J. Lipska et al.   JAMA Internal Medicine